Variant report
Variant | esv3328639 |
---|---|
Chromosome Location | chr9:7286200-7286658 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573344559 | chr9:7286229-7286230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200098635 | chr9:7286234-7286235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201367788 | chr9:7286235-7286236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139332333 | chr9:7286241-7286242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370761671 | chr9:7286253-7286254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10976178 | chr9:7286273-7286274 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs150007606 | chr9:7286278-7286279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115883109 | chr9:7286315-7286316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562515925 | chr9:7286317-7286318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374605560 | chr9:7286381-7286382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549221123 | chr9:7286392-7286393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs13296023 | chr9:7286404-7286405 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs534816100 | chr9:7286450-7286451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376172137 | chr9:7286454-7286455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546421720 | chr9:7286480-7286481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189925140 | chr9:7286495-7286496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538663440 | chr9:7286498-7286499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10976179 | chr9:7286499-7286500 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs575274621 | chr9:7286500-7286501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2770726 | chr9:7286501-7286502 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs145372850 | chr9:7286510-7286511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148765263 | chr9:7286530-7286531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540810866 | chr9:7286545-7286546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565071596 | chr9:7286562-7286563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4742322 | chr9:7286599-7286600 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs548345400 | chr9:7286601-7286602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:7284800-7288600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr9:7285200-7286600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr9:7285200-7287000 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr9:7285200-7287000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr9:7285200-7287000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr9:7285200-7301600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr9:7285400-7287000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr9:7285400-7287200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:7285400-7289800 | Weak transcription | H1 Cell Line | embryonic stem cell |
10 | chr9:7285600-7286800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr9:7285600-7289200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr9:7286600-7288400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr9:7286600-7288400 | Enhancers | HUES48 Cell Line | embryonic stem cell |